# Arbutus Biopharma Corp: Form 8-K, filed Oct 6, 2016

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2016-10-06
- Accepted by EDGAR: Oct 6, 2016, 10:22 ET
- Period: 2016-09-30
- Accession: 0000912282-16-000855
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000091228216000855/arbutus8k_100416.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000091228216000855/

## Items reported

- Item 1.02: Termination of a material agreement
- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000091228216000855/arbutus8k_100416.htm

Filed Oct 6, 2016.
Source: SEC EDGAR, the filing index for accession 0000912282-16-000855. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
